Cell Therapeutics Inc. (CTIC) Posts Q4 Loss of 9c/Share
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
EPS Growth %: +100.0%
Financial Fact:
Basic and diluted net loss per common share: -0.1
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +100.0%
Financial Fact:
Basic and diluted net loss per common share: -0.1
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q4 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.
For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- Investors more worried about earnings slowdown than GDP growth slowdown
- First BanCorp (FBP) PT Raised to $21 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
